These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 30267715)
1. Simultaneous activation of muscarinic and GABA Cieślik P; Woźniak M; Tokarski K; Kusek M; Pilc A; Płoska A; Radulska A; Pelikant-Małecka I; Żołnowska B; Sławiński J; Kalinowski L; Wierońska JM Behav Brain Res; 2019 Feb; 359():671-685. PubMed ID: 30267715 [TBL] [Abstract][Full Text] [Related]
2. Serotonergic-Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms. Cieślik P; Radulska A; Burnat G; Kalinowski L; Wierońska JM Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445318 [TBL] [Abstract][Full Text] [Related]
3. Involvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022. Woźniak M; Acher F; Marciniak M; Lasoń-Tyburkiewicz M; Gruca P; Papp M; Pilc A; Wierońska JM Curr Neuropharmacol; 2016; 14(5):413-26. PubMed ID: 26769224 [TBL] [Abstract][Full Text] [Related]
4. mGlu₅-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia. Wierońska JM; Kłeczek N; Woźniak M; Gruca P; Łasoń-Tyburkiewicz M; Papp M; Brański P; Burnat G; Pilc A Neurochem Int; 2015 Sep; 88():97-109. PubMed ID: 25863284 [TBL] [Abstract][Full Text] [Related]
5. Mutual activation of glutamatergic mGlu Cieślik P; Woźniak M; Rook JM; Tantawy MN; Conn PJ; Acher F; Tokarski K; Kusek M; Pilc A; Wierońska JM Psychopharmacology (Berl); 2018 Oct; 235(10):2897-2913. PubMed ID: 30054675 [TBL] [Abstract][Full Text] [Related]
6. Reversal of MK-801-Induced Disruptions in Social Interactions and Working Memory with Simultaneous Administration of LY487379 and VU152100 in Mice. Cieślik P; Radulska A; Pelikant-Małecka I; Płoska A; Kalinowski L; Wierońska JM Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31174329 [TBL] [Abstract][Full Text] [Related]
7. The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice. Wierońska JM; Kusek M; Tokarski K; Wabno J; Froestl W; Pilc A Br J Pharmacol; 2011 Jul; 163(5):1034-47. PubMed ID: 21371011 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100. Byun NE; Grannan M; Bubser M; Barry RL; Thompson A; Rosanelli J; Gowrishankar R; Kelm ND; Damon S; Bridges TM; Melancon BJ; Tarr JC; Brogan JT; Avison MJ; Deutch AY; Wess J; Wood MR; Lindsley CW; Gore JC; Conn PJ; Jones CK Neuropsychopharmacology; 2014 Jun; 39(7):1578-93. PubMed ID: 24442096 [TBL] [Abstract][Full Text] [Related]
9. Prevention of MK-801-induced amnestic effect with combined activation of 5-HT Cieślik P; Rafało-Ulińska A; Wierońska JM Pharmacol Biochem Behav; 2024 May; 238():173749. PubMed ID: 38462045 [TBL] [Abstract][Full Text] [Related]
12. The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents. Sławińska A; Wierońska JM; Stachowicz K; Marciniak M; Lasoń-Tyburkiewicz M; Gruca P; Papp M; Kusek M; Tokarski K; Doller D; Pilc A Br J Pharmacol; 2013 Aug; 169(8):1824-39. PubMed ID: 23714045 [TBL] [Abstract][Full Text] [Related]
13. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848 [TBL] [Abstract][Full Text] [Related]